These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29562221)

  • 1. Assessment of Physician's Systemic Treatment Preferences for Patients with Advanced Desmoid-Type Fibromatosis: Experience-Based Medicine in the Absence of High-Level Evidence.
    Schöffski P; Requilé A; van Cann T
    Oncol Res Treat; 2018; 41(4):214-219. PubMed ID: 29562221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.
    Fiore M; Colombo C; Radaelli S; Callegaro D; Palassini E; Barisella M; Morosi C; Baldi GG; Stacchiotti S; Casali PG; Gronchi A
    Eur J Cancer; 2015 Dec; 51(18):2800-7. PubMed ID: 26602014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin.
    Longhi A; Errani C; Battaglia M; Alberghini M; Ferrari S; Mercuri M; Molinari M
    Ear Nose Throat J; 2011 Jun; 90(6):E11-5. PubMed ID: 21674455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncytotoxic drug therapy in children with unresectable desmoid tumors.
    Lackner H; Urban C; Kerbl R; Schwinger W; Beham A
    Cancer; 1997 Jul; 80(2):334-40. PubMed ID: 9217047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
    Sobczuk P; Agnieszczak IM; Grycuk W; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Morysiński T; Zdzienicki M; Rutkowski P
    Eur J Surg Oncol; 2021 Oct; 47(10):2602-2608. PubMed ID: 33994241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
    J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.
    Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of desmoid-type fibromatosis: mechanism, current situation, and future prospects.
    Wang Z; Wu J; Tian X; Hao C
    Front Med; 2019 Aug; 13(4):427-437. PubMed ID: 30798508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
    Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
    Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term experience with therapy of a female patient with Gardner's syndrome, first presenting with extra-abdominal desmoid tumor, and review of the literature].
    Mátrai Z; Papp J; Polgár C; Hitre E; Köves I; Oláh E; Andi J; Kiss A; Vámosi Nagy I; Tóth L; Orosz Z
    Magy Seb; 2009 Apr; 62(2):75-82. PubMed ID: 19386568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.
    Krop IE; Kim SB; Martin AG; LoRusso PM; Ferrero JM; Badovinac-Crnjevic T; Hoersch S; Smitt M; Wildiers H
    Lancet Oncol; 2017 Jun; 18(6):743-754. PubMed ID: 28526538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
    Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
    Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life experience with sorafenib for advanced and refractory desmoid-type fibromatosis.
    Schampers D; Decruyenaere A; Jacobs C; Lapeire L
    Acta Oncol; 2024 Aug; 63():607-611. PubMed ID: 39099320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
    Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
    Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
    Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoid fibromatosis: MRI features of response to systemic therapy.
    Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
    Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.